Abiopharma

DANAHER CORP /DE/ (DHR)

Symbol	DHR
Name	DANAHER CORP /DE/
Sector	UNDEFINED
Region	UNDEFINED
Industry	Industrial Instruments For Measurement, Display, and Control
Address	2200 PENNSYLVANIA AVE. N.W., WASHINGTON, DC 20037-1701
Telephone	2028280850
Fax	—
Email	—
Website	—
Incorporation	UNDEFINED
Incorporated On	—
Employees	—
Fiscal Year	—
Public Since	—
Exchanges	NASDAQ
Auditor	—
Audit Status	NOT PROVIDED
Reporting Status	—
CIK	0000313616
Description	None

2026-05-07 20:36

(99% Neutral) DANAHER CORP /DE/ (DHR) Announces Executive Changes

2026-05-06 20:15

Danaher to Present at Bank of America Securities Healthcare Conference

2026-05-05 20:30

Danaher Announces Quarterly Dividend

2026-05-04 21:00

Director SPOON ALAN G 🟡 adjusted position in 1.4K shares (1 derivative) of DANAHER CORP /DE/ (DHR) at $174.67 Transaction Date: May 01, 2026 | Filing ID: 000125

2026-05-01 19:05

📋 SPOON ALAN G (Director) plans to sell 1K shares of DANAHER CORP /DE/ (at $174.67 each, total $237K) Filed: May 01, 2026 | ID: 003194

2026-04-30 13:10

New Form CERT - DANAHER CORP /DE/ Filed: 2026-04-30 AccNo: 0000876661-26-000375 Size: 463 KB

2026-04-29 20:14

(99% Neutral) DANAHER CORP /DE/ (DHR) Announces Business Combination

2026-04-29 19:14

New Form SCHEDULE 13G - DANAHER CORP /DE/ Filed: 2026-04-29 AccNo: 0002100119-26-000404 Size: 7 KB

2026-04-29 17:42

New Form 8-A12B - DANAHER CORP /DE/ Filed: 2026-04-29 AccNo: 0001193125-26-192012 Size: 19 KB

2026-04-28 21:01

Director Stevens Raymond C 🟢 acquired 199 shares (1 derivative) of DANAHER CORP /DE/ (DHR) Transaction Date: Apr 24, 2026 | Filing ID: 000123